<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Twist Bioscience Corp — News on 6ix</title>
<link>https://6ix.com/company/twist-bioscience-corp</link>
<description>Latest news and press releases for Twist Bioscience Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/twist-bioscience-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835ce4078dffbe2df11e5ef.webp</url>
<title>Twist Bioscience Corp</title>
<link>https://6ix.com/company/twist-bioscience-corp</link>
</image>
<item>
<title>Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-to-report-fiscal-2026-second-quarter-financial-results-on-monday-may-4-2026</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-to-report-fiscal-2026-second-quarter-financial-results-on-monday-may-4-2026</guid>
<pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif., April 21, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the fiscal 2026 second quarter ended March 31, 2026, before the opening of the market on May 4, 2026. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. T</description>
</item>
<item>
<title>Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-expands-antibody-discovery-offering-with-bispecific-licensing-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-expands-antibody-discovery-offering-with-bispecific-licensing-agreement</guid>
<pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif., February 17, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has entered into a licensing agreement with Invenra Inc. ("Invenra"), a company that has developed platform technologies to discover therapeutic antibody candidates. Under the terms of the agreement, Twist will become the co-exclusive provider, together with Invenra, of Invenra’s B-Body® bispecific antibody platform ("B-Body platform"),</description>
</item>
<item>
<title>Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-launches-next-generation-130000833</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-launches-next-generation-130000833</guid>
<pubDate>Tue, 10 Feb 2026 13:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif., February 10, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit and Twist PCR-Free WGS Library Preparation Kit, each designed to address a wide range of sample input, including low input and challenging sample types, to enable clinical research.</description>
</item>
<item>
<title>Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-rule</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-rule</guid>
<pubDate>Tue, 03 Feb 2026 05:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST), a company</description>
</item>
<item>
<title>Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-fiscal-2026-121500503</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-fiscal-2026-121500503</guid>
<pubDate>Mon, 02 Feb 2026 12:15:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif., February 02, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the first quarter fiscal 2026 ended December 31, 2025.</description>
</item>
<item>
<title>Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-preliminary-first-quarter-fiscal-2026-revenue-2026-01-12</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-preliminary-first-quarter-fiscal-2026-revenue-2026-01-12</guid>
<pubDate>Mon, 12 Jan 2026 05:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced</description>
</item>
<item>
<title>Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-present-jp-morgan-2026-healthcare-conference-2025-12-18</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-present-jp-morgan-2026-healthcare-conference-2025-12-18</guid>
<pubDate>Thu, 18 Dec 2025 05:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that</description>
</item>
<item>
<title>Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-launches-new-plasmid-preps-enable-nucleic-acid-therapeutics-research</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-launches-new-plasmid-preps-enable-nucleic-acid-therapeutics-research</guid>
<pubDate>Thu, 04 Dec 2025 05:00:00 GMT</pubDate>
<description>Offering includes Animal Origin-Free Preps, Transfection-Grade Preps and Target Yield with turnaround time starting at four business days for Express Genes</description>
</item>
<item>
<title>Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-fiscal-2025-fourth-quarter-and-full-year-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-fiscal-2025-fourth-quarter-and-full-year-financial-results</guid>
<pubDate>Fri, 14 Nov 2025 05:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced</description>
</item>
<item>
<title>Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-present-7th-annual-wolfe-research-healthcare-conference-2025-11-04</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-present-7th-annual-wolfe-research-healthcare-conference-2025-11-04</guid>
<pubDate>Tue, 04 Nov 2025 05:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that</description>
</item>
<item>
<title>Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-report-fiscal-2025-fourth-quarter-and-full-year-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-report-fiscal-2025-fourth-quarter-and-full-year-financial-results</guid>
<pubDate>Thu, 23 Oct 2025 04:00:00 GMT</pubDate>
<description>Company to host conference call at 8:00 AM ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth</description>
</item>
<item>
<title>Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-and-element-biosciences-advance-collaboration-launch-new-trinity</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-and-element-biosciences-advance-collaboration-launch-new-trinity</guid>
<pubDate>Mon, 06 Oct 2025 04:00:00 GMT</pubDate>
<description>-- Launch of End-to-End Workflow for AVITI and AVITI24™ Enabling Sample to Sequencer in as Little as Five Hours -- -- Twist Gains Exclusive Access to the</description>
</item>
<item>
<title>Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-publication-science-examining-biosecurity-screening</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-publication-science-examining-biosecurity-screening</guid>
<pubDate>Thu, 02 Oct 2025 04:00:00 GMT</pubDate>
<description>Study and red-teaming exercise led by Microsoft brought together consortium of scientific and industry experts Twist remains at the forefront of biosecurity</description>
</item>
<item>
<title>Twist Bioscience to Present at Baird 2025 Global Healthcare Conference</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-present-baird-2025-global-healthcare-conference-2025-09-03</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-present-baird-2025-global-healthcare-conference-2025-09-03</guid>
<pubDate>Wed, 03 Sep 2025 04:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that</description>
</item>
<item>
<title>Twist Bioscience Collaborates with Synthetic Design Lab</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-collaborates-synthetic-design-lab-2025-09-02</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-collaborates-synthetic-design-lab-2025-09-02</guid>
<pubDate>Tue, 02 Sep 2025 04:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that</description>
</item>
<item>
<title>Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-launches-oncology-dna-cgp-panel-advance-precision-medicine</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-launches-oncology-dna-cgp-panel-advance-precision-medicine</guid>
<pubDate>Tue, 19 Aug 2025 04:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity, in the life sciences</description>
</item>
<item>
<title>Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-appoints-trynka-shineman-blake-board-directors-2025-08-06</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-appoints-trynka-shineman-blake-board-directors-2025-08-06</guid>
<pubDate>Wed, 06 Aug 2025 04:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced the appointment of</description>
</item>
<item>
<title>Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results-2025-08-04</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results-2025-08-04</guid>
<pubDate>Mon, 04 Aug 2025 04:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results</description>
</item>
<item>
<title>Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-expands-vivo-antibody-discovery-services-launch-humanized-transgenic</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-expands-vivo-antibody-discovery-services-launch-humanized-transgenic</guid>
<pubDate>Thu, 31 Jul 2025 04:00:00 GMT</pubDate>
<description>HuTg can be coupled with Twist hyperimmune DiversimAb mouse model and B cell screening methods SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist</description>
</item>
<item>
<title>Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-rule-1</link>
<guid isPermaLink="true">https://6ix.com/company/twist-bioscience-corp/news/twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-rule-1</guid>
<pubDate>Thu, 24 Jul 2025 04:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST), a company</description>
</item>
</channel>
</rss>